Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
Guillaume Fond, Noémie Resseguier, Franck Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience (2017) Vol. 268, Iss. 6, pp. 541-553
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The Role of Inflammation in the Treatment of Schizophrenia
Guillaume Fond, Christophe Lançon, Théo Korchia, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 113
C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 76
Smoking in schizophrenia
Marina Šagud, Alma Mihaljević Peleš, Nela Pivac
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 5, pp. 402-408
Open Access | Times Cited: 75
Microbiota-Orientated Treatments for Major Depression and Schizophrenia
Guillaume B. Fond, Jean‐Christophe Lagier, Stéphane Honoré, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1024-1024
Open Access | Times Cited: 57
Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis
Valentine Lestra, Bruno Roméo, Catherine Martelli, et al.
Schizophrenia Research (2022) Vol. 246, pp. 175-186
Open Access | Times Cited: 31
Increased random exploration in schizophrenia is associated with inflammation
Flurin Cathomas, Federica Klaus, Karoline Guetter, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Deciphering microbiome and neuroactive immune gene interactions in schizophrenia
Emily G. Severance, Robert H. Yolken
Neurobiology of Disease (2018) Vol. 135, pp. 104331-104331
Open Access | Times Cited: 33
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
The association between anti-inflammatory effects of long-term lithium treatment and illness course in Bipolar Disorder.
Robert Queissner, Melanie Lenger, Armin Birner, et al.
Journal of Affective Disorders (2020) Vol. 281, pp. 228-234
Open Access | Times Cited: 22
The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals
María Juncal‐Ruíz, Laura Riesco-Dávila, Víctor Ortiz‐García de la Foz, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes
Beatriz Praena, Raquel Bello-Morales, Fernando de Castro, et al.
Antiviral Research (2019) Vol. 168, pp. 91-99
Open Access | Times Cited: 20
The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia
Tong Zhu, Jing Zhu, Jiajia Wang, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 12
Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
Conor Kelly, Joseph P. McEvoy, Brian J. Miller
Schizophrenia Research (2019) Vol. 209, pp. 193-197
Closed Access | Times Cited: 18
C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders
Laura Orsolini, Simone Pompili, Umberto Volpe
Advances in experimental medicine and biology (2023), pp. 135-160
Closed Access | Times Cited: 6
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort
G. Fond, O. Godin, Marion Dumontaud, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109654-109654
Open Access | Times Cited: 14
Unmetabolized quetiapine exerts an in vitro effect on innate immune cells by modulating inflammatory response and neutrophil extracellular trap formation
Bárbara Osmarin Turra, Fernanda Barbisan, Verônica Farina Azzolin, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110497-110497
Open Access | Times Cited: 13
Effect of quetiapine on inflammation and immunity: a systematic review
Marco Ferrari, M. Godio, Stefano De Martini, et al.
International Journal of Psychiatry in Clinical Practice (2022) Vol. 27, Iss. 2, pp. 196-207
Closed Access | Times Cited: 8
Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia
G. Fond, Jean‐Arthur Micoulaud‐Franchi, Mélanie Faugère, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 97, pp. 109800-109800
Open Access | Times Cited: 12
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis
Farivar Fathian, Rolf Gjestad, Rune A. Kroken, et al.
Schizophrenia Research (2022) Vol. 241, pp. 174-183
Open Access | Times Cited: 7
Sex-specific associations of plasma neutrophil gelatinase-associated lipocalin (NGAL) with cognition in patients with drug-naïve schizophrenia
Meijuan Li, Xiaoli Wang, Siying Kong, et al.
Journal of Psychiatric Research (2024) Vol. 174, pp. 19-25
Closed Access | Times Cited: 1
Altered proteomic profile in umbilical arterial serum from mothers with schizophrenia
Yoshinori Moriyama, Tomomi Kotani, Takafumi Ushida, et al.
Schizophrenia Research (2018) Vol. 197, pp. 615-617
Closed Access | Times Cited: 11
Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences
Francesco Dal Santo, Leticia González-Blanco, Leticia García-Álvarez, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Peripheral inflammation is associated with brain SPECT perfusion changes in schizophrenia
Guillaume Fond, Alexandra Garosi, Mélanie Faugère, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 3, pp. 905-912
Open Access | Times Cited: 8
Improving the treatment and remission of major depression in homeless people with severe mental illness: The multicentric French Housing First (FHF) program
Guillaume Fond, Aurélie Tinland, Mohamed Boucékine, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109877-109877
Open Access | Times Cited: 8
Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
Guillaume Fond, Mélanie Faugère, Raphaëlle Richieri, et al.
Journal of Affective Disorders (2020) Vol. 280, pp. 267-271
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top